Evidence map›Paper›PMID 24603971›Full record

ArticlePloS one2014

Detection of chromosomal breakpoints in patients with developmental delay and speech disorders.

Kagistia H Utami, Axel M Hillmer, Irene Aksoy, Elaine G Y Chew, Audrey S M Teo, Zhenshui Zhang, Charlie W H Lee, Pauline J Chen, Chan Chee Seng, Pramila N Ariyaratne and 20 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Genetic variants in RBFOX3 are associated with sleep latency.European journal of human genetics : EJHG · 2016
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 7 institutions in 3 countries.

Kagistia H UtamiHuman Genetics, Genome Institute of Singapore, Singapore, Singapore; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Axel M HillmerCancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore.
Irene AksoyStem Cells and Developmental Biology, Genome Institute of Singapore, Singapore, Singapore.
Elaine G Y ChewCancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore.
Audrey S M TeoCancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore.
Zhenshui ZhangCancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore.
Charlie W H LeeComputational and Mathematical Biology, Genome Institute of Singapore, Singapore, Singapore.
Pauline J ChenComputational and Mathematical Biology, Genome Institute of Singapore, Singapore, Singapore.
Chan Chee SengScientific & Research Computing, Genome Institute of Singapore, Singapore, Singapore.
Pramila N AriyaratneComputational and Mathematical Biology, Genome Institute of Singapore, Singapore, Singapore.
Sigrid L RouamComputational and Mathematical Biology, Genome Institute of Singapore, Singapore, Singapore.
Lim Seong SooHuman Genetics, Genome Institute of Singapore, Singapore, Singapore.
Saira YousoofEye and Developmental Genetics Research, The Children's Hospital at Westmead, Children's Medical Research Institute and Save Sight Institute, Sydney, New South Wales, Australia; Disciplines of Paediatrics and Child Health and Genetic Medicine, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Ivan ProkudinEye and Developmental Genetics Research, The Children's Hospital at Westmead, Children's Medical Research Institute and Save Sight Institute, Sydney, New South Wales, Australia; Disciplines of Paediatrics and Child Health and Genetic Medicine, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Gregory PetersDepartment of Cytogenetics, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Felicity CollinsDepartment of Clinical Genetics, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Meredith WilsonDepartment of Clinical Genetics, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Alyson KakakiosDepartment of Immunology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Georges HaddadUnité de Génétique, Centre Hospitalier, Blois, France.
Arnaud MenuetService de Genetique INEM UMR7355 CNRS-University, Centre Hospitalier Régional d'Orléans, Orléans, France.
Olivier PercheService de Genetique INEM UMR7355 CNRS-University, Centre Hospitalier Régional d'Orléans, Orléans, France.
Stacey Kiat Hong TayDepartment of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Ken W K SungComputational and Mathematical Biology, Genome Institute of Singapore, Singapore, Singapore.
Xiaoan RuanGenome Technology and Biology, Genome Institute of Singapore, Singapore, Singapore.
Yijun RuanGenome Technology and Biology, Genome Institute of Singapore, Singapore, Singapore.
Edison T LiuCancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore.
Sylvain BriaultService de Genetique INEM UMR7355 CNRS-University, Centre Hospitalier Régional d'Orléans, Orléans, France.
Robyn V JamiesonEye and Developmental Genetics Research, The Children's Hospital at Westmead, Children's Medical Research Institute and Save Sight Institute, Sydney, New South Wales, Australia.
Sonia DavilaHuman Genetics, Genome Institute of Singapore, Singapore, Singapore.
Valere CacheuxHuman Genetics, Genome Institute of Singapore, Singapore, Singapore.
Genome Institute of Singapore · SGChildren's Hospital at Westmead · AUCentre hospitalier régional d'Orléans · FRCentre National de la Recherche Scientifique · FRChildren's Medical Research Institute · AUNational University of Singapore · SGUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Delineating candidate genes at the chromosomal breakpoint regions in the apparently balanced chromosome rearrangements (ABCR) has been shown to be more effective with the emergence of next-generation sequencing (NGS) technologies. We employed a large-insert (7-11 kb) paired-end tag sequencing technology (DNA-PET) to systematically analyze genome of four patients harbouring cytogenetically defined ABCR with neurodevelopmental symptoms, including developmental delay (DD) and speech disorders. We characterized structural variants (SVs) specific to each individual, including those matching the chromosomal breakpoints. Refinement of these regions by Sanger sequencing resulted in the identification of five disrupted genes in three individuals: guanine nucleotide binding protein, q polypeptide (GNAQ), RNA-binding protein, fox-1 homolog (RBFOX3), unc-5 homolog D (C.elegans) (UNC5D), transmembrane protein 47 (TMEM47), and X-linked inhibitor of apoptosis (XIAP). Among them, XIAP is the causative gene for the immunodeficiency phenotype seen in the patient. The remaining genes displayed specific expression in the fetal brain and have known biologically relevant functions in brain development, suggesting putative candidate genes for neurodevelopmental phenotypes. This study demonstrates the application of NGS technologies in mapping individual gene disruptions in ABCR as a resource for deciphering candidate genes in human neurodevelopmental disorders (NDDs).

Indexed as

Chromosome BreakpointsBase SequenceChromosome InversionDevelopmental DisabilitiesDNA Copy Number VariationsFemaleGenetic Association StudiesHigh-Throughput Nucleotide SequencingHumansLanguage Development DisordersMaleMolecular Sequence DataPedigreeSequence Analysis, DNATranslocation, Genetic

Identifiers

PMID24603971
PMCPMC3946304
OpenAlexW2028986491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.